Related Experiment Video

Updated: Aug 8, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Physiological analysis of oncogenic K-ras

Pedro Antonio Pérez-Mancera1, David A Tuveson

  • 1University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA.

Methods in Enzymology
|June 8, 2006
PubMed

Insights

Activating KRAS mutations drive cancer, but their effects are poorly understood. Using conditional mutations in endogenous Kras alleles offers a better system to study KRAS oncogenic properties and develop therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Activating mutations in KRAS are common in pancreatic cancer and other neoplasms.
  • The precise molecular and cellular mechanisms of mutant KRAS oncogenesis remain insufficiently understood, hindering effective therapeutic strategies.
  • Previous studies using supraphysiological Ras expression showed premature senescence, contrasting with endogenous Ras expression conferring immortalization in murine cells.

Purpose of the Study:

  • To review the utility of conditional oncogenic mutations in the endogenous Kras allele.
  • To explore the biochemistry, cell biology, and tumor modeling of oncogenic Kras.
  • To address the discrepancy between previous findings and the biological reality of oncogenic Ras.

Main Methods:

  • Review of existing literature on oncogenic Ras.
  • Focus on studies utilizing conditional mutations in the endogenous Kras allele.
  • Analysis of systems modeling oncogenic Kras effects.

Main Results:

  • Supraphysiological oncogenic Ras expression induces premature senescence.
  • Endogenous oncogenic Ras expression promotes immortalization in primary murine cells.
  • Conditional mutations in endogenous Kras alleles provide a more accurate system for studying oncogenic Ras.

Conclusions:

  • The predominant biological systems used to evaluate oncogenic Ras may not accurately reflect its true properties.
  • Conditional mutations in endogenous Kras alleles represent a valuable system for investigating oncogenic Kras.
  • This approach can advance our understanding of KRAS-driven cancers and inform therapeutic development.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...